Debrecen, Hungary

Janos Rako

This inventor holds 1 USPTO granted patent. Top assignee: Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Janos Rako. Retrieved from https://idiyas.com/inventor/janos-rako

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Janos Rako

Introduction

Janos Rako is a notable inventor based in Debrecen, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly in the extraction of valuable compounds from biomatter. His work has implications for the development of important medications.

Latest Patents

Janos Rako holds a patent for a method for extracting a macrolide from biomatter. This method is particularly focused on obtaining macrolides such as tacrolimus, ascomycin, pimecrolimus, sirolimus, or everolimus. This innovation is crucial for enhancing the efficiency of drug production from natural sources.

Career Highlights

Rako is currently employed at Teva Gyógyszergyár Zártkörüen Müködö Részvénytársaság, a leading pharmaceutical company. His role involves research and development, where he applies his expertise to advance pharmaceutical technologies. His work has contributed to the company's reputation for innovation in drug manufacturing.

Collaborations

Janos Rako has collaborated with notable colleagues, including Vilmos Keri and Ferenc Rantal. These partnerships have fostered a productive environment for research and development, leading to advancements in their respective fields.

Conclusion

Janos Rako's contributions to the field of pharmaceuticals through his innovative patent and collaborative efforts highlight his importance as an inventor. His work continues to influence the development of essential medications derived from biomatter.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…